Preclin Biosystems
about us our models news and links join us contact us disclaimer
 
Models

Infectious disease

Autoimmune diseases

Lung diseases

Intestinal diseases

Preclin Biosystems’ approach

Preclin Biosystems AG

Preclin Biosystems AG offers a comprehensive in vivo preclinical testing platform for the identification and validation of lead candidate therapeutics.

Our extensive range of chronic inflammatory and infectious disease models are run routinely in our core facility providing a ‘one stop shop’ for preclinical drug efficacy testing. Our parallel testing approach for in vivo assessment of lead candidates can provide an overall efficacy, side effect and target market analysis condensing the preclinical phase of drug development dramatically. For more information on our service and partnership opportunities contact: info@preclinbiosystems.com
News

November 2014: Meet Preclin Biosystems AG at the BioEurope 2014 conference in Frankfurt (3-5 November). To schedule a meeting contact:
info@preclinbiosystems.com

September 2014: Meet Preclin Biosystems AG at the BioPharm America 2014 conference in Boston (22-24 September). To schedule a meeting contact:
info@preclinbiosystems.com

June 2014: Meet Preclin Biosystems AG at the Bio International Convention 2014 in San Diego (23-26 June). To schedule a meeting contact:
info@preclinbiosystems.com

May 2014: Meet Preclin Biosystems AG at the BioTrinity 2014 conference in London (12-14 May). To schedule a meeting contact:
info@preclinbiosystems.com

April 2014: Meet Preclin Biosystems AG at the Swiss Biotech Day 2014 conference in Zurich (8 April).
To schedule a meeting contact:
info@preclinbiosystems.com

March 2014: Meet Preclin Biosystems AG at the Bio-Europe Spring 2014 conference in Turin (10-12 March). To schedule a meeting contact:
info@preclinbiosystems.com


HOME | ABOUT US | OUR MODELS | NEWS & LINKS | JOIN US | CONTACT | DISCLAIMER info@preclinbiosystems.com
© Preclin Biosystems AG, all rights reserved